Clinical trial
Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy…
NCT00023829 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00023829 |
|---|---|
| Title | Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer |
| Official title | Phase III Randomized Study of Adjuvant Therapy for High Risk pT3N0 Prostate Cancer |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH NCIC Clinical Trials Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | bicalutamide, flutamide, releasing hormone agonist therapy, adjuvant therapy, radiation therapy |
| Enrollment | 67 |
| Start date | Aug 1, 2001 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 22, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: